108 related articles for article (PubMed ID: 2984056)
1. Establishment and characterization of an Epstein-Barr virus nuclear antigen-negative hairy cell line.
Lang AB; Odermatt BF; Gut DR; Rüttner JR
Exp Cell Biol; 1985; 53(2):61-8. PubMed ID: 2984056
[TBL] [Abstract][Full Text] [Related]
2. Analysis of transformation with Epstein-Barr virus and phenotypic characteristics of lymphoblastoid cell lines established from patients with hairy cell leukemia.
Sairenji T; Spiro RC; Reisert PS; Paquin L; Sakamoto K; Shibuya A; Sullivan JL; Katayama I; Humphreys RE
Am J Hematol; 1983 Dec; 15(4):361-74. PubMed ID: 6316777
[TBL] [Abstract][Full Text] [Related]
3. Restrictions upon Epstein-Barr virus infection of the leukemic cell are demonstrated in patients with hairy cell leukemia.
Sairenji T; Reisert PS; Spiro RC; Mulder C; Humphreys RE
Hematol Oncol; 1983; 1(3):251-62. PubMed ID: 6329936
[TBL] [Abstract][Full Text] [Related]
4. Hairy cell leukemia: establishment of a cell line and its characteristics.
Miyoshi I; Hiraki S; Tsubota T; Hikita T; Masuji H; Nishi Y; Kimura I
Cancer; 1981 Jan; 47(1):60-5. PubMed ID: 6257373
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of permanent cell lines from patients with acute and hairy cell leukemia.
Stöckbauer P; Cinátl J; Mach O
Neoplasma; 1981; 28(4):385-95. PubMed ID: 6270579
[TBL] [Abstract][Full Text] [Related]
6. The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization.
Wolf BC; Martin AW; Neiman RS; Janckila AJ; Yam LT; Caracansi A; Leav BA; Winpenny R; Schultz DS; Wolfe HJ
Am J Pathol; 1990 Mar; 136(3):717-23. PubMed ID: 2156435
[TBL] [Abstract][Full Text] [Related]
7. Characterisation of a new cell line (CJ18) from a patient with 'hairy' cell leukaemia.
Skinnider LF; Ha T; Bergen S; Wang HC
Scand J Haematol; 1985 Oct; 35(4):430-6. PubMed ID: 4081642
[TBL] [Abstract][Full Text] [Related]
8. The establishment of Epstein-Barr virus nuclear antigen-positive (SP-50B) and Epstein-Barr virus nuclear antigen-negative (SP-53) cell lines with t(11;14)(q13;q32) chromosome abnormality from an intermediate lymphocytic lymphoma.
Daibata M; Kubonishi I; Eguchi T; Yano S; Ohtsuki Y; Miyoshi I
Cancer; 1989 Sep; 64(6):1248-53. PubMed ID: 2548699
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus nuclear antigen (EBNA): size polymorphism of EBNA 1.
Allday MJ; MacGillivray AJ
J Gen Virol; 1985 Jul; 66 ( Pt 7)():1595-600. PubMed ID: 2991431
[TBL] [Abstract][Full Text] [Related]
10. Establishment of an Epstein-Barr virus-determined nuclear antigen-negative human B-cell line from acute lymphoblastic leukemia.
Hiraki S; Miyoshi I; Masuji H; Kubonishi I; Matsuda Y
J Natl Cancer Inst; 1977 Jul; 59(1):93-4. PubMed ID: 195075
[TBL] [Abstract][Full Text] [Related]
11. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
Ernberg I; Kallin B; Dillner J; Falk K; Ehlin-Henriksson B; Hammarskjöld ML; Klein G
Int J Cancer; 1986 Nov; 38(5):729-37. PubMed ID: 3021635
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
Sculley TB; Spelsberg TC; Pearson GR
Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus nuclear antigen type 1 binding: electron microscopy.
Hirsch I; Reischig J; Benada O; Bartsch D; Brichácek B; Boguszaková L; Vonka V
J Virol Methods; 1988 Dec; 22(2-3):133-42. PubMed ID: 2851598
[TBL] [Abstract][Full Text] [Related]
14. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
[TBL] [Abstract][Full Text] [Related]
15. Cytochemical, cytogenetic, immunophenotypic and tumorigenic characterization of two hairy cell lines.
Faguet GB; Satya-Prakash KL; Agee JF
Blood; 1988 Feb; 71(2):422-9. PubMed ID: 2827813
[TBL] [Abstract][Full Text] [Related]
16. Appearance of Epstein-Barr virus nuclear antigen in human cordblood lymphocytes.
Wright J; Falk L; Deinhardt F
IARC Sci Publ (1971); 1975; (11 Pt 1):409-14. PubMed ID: 190146
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation.
Harvey W; Srour EF; Turner R; Carey R; Maze R; Starrett B; Kanagala R; Pereira D; Merchant P; Taylor M
Leuk Res; 1991; 15(8):733-44. PubMed ID: 1895754
[TBL] [Abstract][Full Text] [Related]
18. Changes in the expression of two Epstein-Barr virus-associated antigens, EBNA and RANA, during the cell cycle of transformed human B lymphoblasts.
Slovin SF; Vaughan JH; Carson DA
Int J Cancer; 1980 Jul; 26(1):9-12. PubMed ID: 6263806
[TBL] [Abstract][Full Text] [Related]
19. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus.
Fresen KO; zur Hausen H
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313
[TBL] [Abstract][Full Text] [Related]
20. Blocking of acid-fixed nuclear binding of Epstein-Barr virus nuclear antigen (EBNA) by different DNA species.
Hirsch I; Kuchlerová L; Brichácek B; Suchánková A; Vonka V
J Gen Virol; 1979 Sep; 44(3):849-52. PubMed ID: 231093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
